The spectrum of intermediate SCN8A-related epilepsy.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
05 2019
Historique:
received: 29 10 2018
revised: 07 03 2019
accepted: 07 03 2019
pubmed: 11 4 2019
medline: 28 4 2020
entrez: 11 4 2019
Statut: ppublish

Résumé

Pathogenic variants in SCN8A have been associated with a wide spectrum of epilepsy phenotypes, ranging from benign familial infantile seizures (BFIS) to epileptic encephalopathies with variable severity. Furthermore, a few patients with intellectual disability (ID) or movement disorders without epilepsy have been reported. The vast majority of the published SCN8A patients suffer from severe developmental and epileptic encephalopathy (DEE). In this study, we aimed to provide further insight on the spectrum of milder SCN8A-related epilepsies. A cohort of 1095 patients were screened using a next generation sequencing panel. Further patients were ascertained from a network of epilepsy genetics clinics. Patients with severe DEE and BFIS were excluded from the study. We found 36 probands who presented with an SCN8A-related epilepsy and normal intellect (33%) or mild (61%) to moderate ID (6%). All patients presented with epilepsy between age 1.5 months and 7 years (mean = 13.6 months), and 58% of these became seizure-free, two-thirds on monotherapy. Neurological disturbances included ataxia (28%) and hypotonia (19%) as the most prominent features. Interictal electroencephalogram was normal in 41%. Several recurrent variants were observed, including Ile763Val, Val891Met, Gly1475Arg, Gly1483Lys, Phe1588Leu, Arg1617Gln, Ala1650Val/Thr, Arg1872Gln, and Asn1877Ser. With this study, we explore the electroclinical features of an intermediate SCN8A-related epilepsy with mild cognitive impairment, which is for the majority a treatable epilepsy.

Identifiants

pubmed: 30968951
doi: 10.1111/epi.14705
doi:

Substances chimiques

Anticonvulsants 0
NAV1.6 Voltage-Gated Sodium Channel 0
SCN8A protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

830-844

Informations de copyright

Wiley Periodicals, Inc. © 2019 International League Against Epilepsy.

Auteurs

Katrine M Johannesen (KM)

Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center Filadelfia, Dianalund, Denmark.
Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark.

Elena Gardella (E)

Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center Filadelfia, Dianalund, Denmark.
Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark.

Alejandra C Encinas (AC)

Graduate Interdisciplinary Program of Genetics, University of Arizona, Tucson, Arizona.

Anna-Elina Lehesjoki (AE)

Folkhälsan Research Center, Helsinki, Finland.
Research Programs Unit, Molecular Neurology and Medicum, University of Helsinki, Helsinki, Finland.

Tarja Linnankivi (T)

Department of Child Neurology, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Michael B Petersen (MB)

Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Ida Charlotte Bay Lund (ICB)

Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.

Susanne Blichfeldt (S)

Department of Pediatrics, Herlev Hospital, Herlev, Denmark.

Maria J Miranda (MJ)

Department of Pediatrics, Herlev Hospital, Herlev, Denmark.

Deb K Pal (DK)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
King's College Hospital, London, UK.
Evelina London Children's Hospital, London, UK.
Medical Research Council Centre for Neurodevelopmental Disorders, King's College, London, UK.

Karine Lascelles (K)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.

Peter Procopis (P)

Children's Hospital, Westmead, Sydney, New South Wales, Australia.
Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

Alessandro Orsini (A)

Pediatric Neurology, Pediatric Clinic, University of Pisa, Pisa, Italy.

Alice Bonuccelli (A)

Pediatric Neurology, Pediatric Clinic, University of Pisa, Pisa, Italy.

Thea Giacomini (T)

Child Neuropsychiatry Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, and Maternal and Children's Sciences, Giannina Gaslini Institute, University of Genoa, Genoa, Italy.

Ingo Helbig (I)

Department of Neuropediatrics, University Medical Center Schleswig Holstein, Kiel, Germany.
Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Christina D Fenger (CD)

Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center Filadelfia, Dianalund, Denmark.

Sanjay M Sisodiya (SM)

Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Bucks, UK.

Laura Hernandez-Hernandez (L)

Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Bucks, UK.

Sundararaman Krithika (S)

Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Bucks, UK.

Melissa Rumple (M)

Pediatric Neurology, Banner Children's Specialists, Glendale, Arizona.

Silvia Masnada (S)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Marialuisa Valente (M)

Genomic and Postgenomic Center, Scientific Institute for Research and Healthcare (IRCCS) Mondino Foundation, Pavia, Italy.

Cristina Cereda (C)

Genomic and Postgenomic Center, Scientific Institute for Research and Healthcare (IRCCS) Mondino Foundation, Pavia, Italy.

Lucio Giordano (L)

Child Neurology and Psychiatry Unit, Civilian Hospital, Brescia, Italy.

Patrizia Accorsi (P)

Child Neurology and Psychiatry Unit, Civilian Hospital, Brescia, Italy.

Sarah E Bürki (SE)

Department of Pediatrics, Division of Child Neurology, University Children's Hospital Bern, University of Bern, Bern, Switzerland.

Margherita Mancardi (M)

Unit of Child Neuropsychiatry, Epilepsy Center, Department of Clinical and Surgical Neuroscience and Rehabilitation, Giannina Gaslini Institute, Genoa, Italy.

Christian Korff (C)

Child Neurology Unit, University Children's Hospital, Geneva, Switzerland.

Renzo Guerrini (R)

Neuroscience Department, Children's Hospital Anna Meyer, University of Florence, Florence, Italy.

Sarah von Spiczak (S)

Department of Neuropediatrics, Christian Albrecht University, Kiel, Germany.
Northern German Epilepsy Center for Children and Adolescents, Schwentinental, Germany.

Dorota Hoffman-Zacharska (D)

Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.

Tomasz Mazurczak (T)

Department of Neurology of Children and Adolescents, Institute of Mother and Child, Warsaw, Poland.

Antonietta Coppola (A)

Department of Neuroscience and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.

Salvatore Buono (S)

Neurology Division, Hospital of National Relevance (AORN), Santobono Pausilipon, Naples, Italy.

Marilena Vecchi (M)

Pediatric Clinic, Hospital Company, University of Padua, Padua, Italy.

Michael F Hammer (MF)

University of Arizona Genetic Core, University of Arizona, Tucson, Arizona.

Costanza Varesio (C)

Brain and Behavior Department, University of Pavia, Pavia, Italy.
Child and Adolescence Neurology Department, IRCCS C. Mondino National Neurological Institute, Pavia, Italy.

Pierangelo Veggiotti (P)

Department of Child Neurology, V. Buzzi Children's Hospital, Milan, Italy.
L. Sacco Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Dennis Lal (D)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.
Genomic Medicine Institute, Lerner Research Institute Cleveland Clinic, Cleveland, Ohio.
Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts.
Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Tobias Brünger (T)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Federico Zara (F)

Laboratory of Neurogenetics and Neuroscience, Department of Head-Neck and Neuroscience, Giannina Gaslini Institute, Genoa, Italy.

Pasquale Striano (P)

Pediatric Neurology, Pediatric Clinic, University of Studies of Pisa, Pisa, Italy.

Guido Rubboli (G)

Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center Filadelfia, Dianalund, Denmark.
University of Copenhagen, Copenhagen, Denmark.

Rikke S Møller (RS)

Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center Filadelfia, Dianalund, Denmark.
Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH